Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions

Cell

Volumn 95, Issue 1, 1998, Pages 55-66

  Saudou, Frédéric ^a,b   Finkbeiner, Steven ^a,b   Devys, Didier ^c   Greenberg, Michael E ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; EMBRYO; HUNTINGTON CHOREA; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALIA;

EID: 0032475931     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81782-1     Document Type: Article

References (38)

1. Baker, S.J., Markowitz, S., Fearon, E.R., Wilson, J.K., and Vogelstein, B. (1990). Suppression of human colorectal carcinoma cell growth by wild type p53. Science 249, 912-915.
2. Becher, M.W., Kotzuk, J.A., Sharp, A.M., Davies, S.W., Bates, G.P., Price, D.L., and Ross, C.A. (1998). Intranuclear neuronal inclusions in Huntington's disease and Dentatorubral and Pallidoluysian atrophy - correlation between the density of inclusions and IT-15 CAG triplet repeat length. Neurobiol. Dis. 4, 387-397.
3. Bessert, D.A., Gutridge, K.L., Dunbar, J.C., and Carlock, L.R. (1995). The identification of a functional nuclear localization signal in the Huntington disease protein. Brain Res. Mol. Brain Res. 33, 165-173.
4. Cooper, J.K., Schilling, G., Peters, M.F., Herring, W.J., Sharp, A.H., Kaminsky, Z., Masone, J., Khan, F.A., Delanoy, M., Borchelt, D.R., et al. (1998). Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783-790.
5. Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L., and Bates, G.P. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
6. Davies, S.W., Beardsall, K., Turmaine, M., DiFiglia, M., Aronin, N., and Bates, G.P. (1998). Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 351, 131-133.
7. De Rooij, K.E., Dorsman, J.C., Smoor, M.A., Den Dunnen, J.T., and Van Ommen, G.J. (1996). Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet. 5, 1093-1099.
8. DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.P., Carraway, R., and Reeves, S.A. (1995). Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
9. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P., and Aronin, N. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
10. Dragunow, M., Faull, R.L., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B., and Mee, E. (1995). In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6, 1053-1057.
11. Emerich, D.F., Winn, S.R., Hantraye, P.M., Peschanski, M., Chen, E.-Y., Chu, Y., McDermott, P., Baetge, E.E., and Kordower, J.H. (1997). Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386, 395-399.
12. Finkbeiner, S., Tavazoie, S.F., Maloratsky, A., Jacobs, K.M., Harris, K.M., and Greenberg, M.E. (1997). CREB: a major mediator of neuronal neurotrophin responses. Neuron 19, 1031-1047.
13. Gerber, H.-P., Seipel, K., Georgiev, O., Hoefferer, M., Hug, M., Rusconi, S., and Schaffner, W. (1994). Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263, 808-811.
14. Goldberg, Y.P., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, H.B., Graham, R.K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N.A., Vaillancourt, J.P., and Hayden, M.R. (1996). Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13, 442-449.
15. Graveland, G.A., Williams, R.S., and DiFiglia, M. (1985). Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770-773.
16. Group THDCR (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
17. Gusella, J.F., McNeil, S., Persichetti, F., Srinidhi, J., Novelletto, A., Bird, E., Faber, P., Vonsattel, J.-P., Myers, R., and MacDonald, M.E. (1996). Huntington' disease. Cold Spring Harb. Symp. Quant. Biol. 61, 615-626.
18. Gutekunst, C.A., Levey, A.I., Heilman, C.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J., and Hersch, S.M. (1995). Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA 92, 8710-8714.
19. Hedreen, J.C., and Folstein, S.E. (1995). Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54, 105-120.
20. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y., and Orr, H.T. (1998). Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, this issue, 41-53.
21. Kudo, N., Khochbin, S., Nishi, K., Kitano, K., Yanagida, M., Yoshida, M., and Horinouchi, S. (1997). Molecular cloning and cell cycle-dependent expression of mammalian crm1, a protein involved in nuclear export of proteins. J. Biol. Chem. 272, 29742-29745.
22. Li, S.-H., and Li, X.-J. (1998). Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7, 777-782.
23. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W., and Bates. G.P. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
24. Martin, J.B., and Gusella, J.F. (1986). Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315, 1267-1276.
25. Martindale, D., Hackam, A., Wieczorek, A., Ellerby, L., Wellington, C., McCutcheon, K., Singaraja, R., Kazemi-Esfarjani, P., Devon, R., Kirn, S.U., Bredesen, D.E., Tufaro, F., and Hayden, M.R. (1998). Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat. Genet. 18, 150-154.
26. Nishi, K., Yoshida, M., Fujiwara, D., Nishikawa, M., Horinouchi, S., and Beppu, T. (1994). Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269, 6320-6324.
27. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
28. Portera-Cailliau, C., Hedreen, J.C., Price, D.L., and Koliatsos, V.E. (1995). Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
29. Reiner, A., Albin, R.L., Anderson, K.D., D'Amato, C.J., Penney, J.B., and Young, A.B. (1988). Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA 85, 5733-5737.
30. Ross, C.A. (1997). Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
31. Sapp, E., Ge, P., Aizawa, H., Bird, E., Penney, J., Young, A.B., Vonsattel, J.P., and DiFiglia, M. (1995). Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64, 397-404.
32. Saudou, F., Devys, D., Trottier, Y., Imbert, G., Stoeckel, M.E., Brice, A., and Mandel, J.L. (1996). Polyglutamine expansions and neurodegenerative diseases. Cold Spring Harb. Symp. Quant. Biol. 61, 639-647.
33. Sharp, A.H., Loev, S.J., Schilling, G., Li, S.H., Li, X.J., Bao, J., Wagster, M.V., Kotzuk, J.A., Steiner, J.P., and Lo, A. (1995). Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074.
34. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., and Tora, L. (1995a). Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403-406.
35. Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.G., and Mandel, J.L. (1995b). Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat. Genet. 10, 104-110.
36. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., and Bird, E.D. (1985). Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
37. Wen, W., Meinkoth, J.L., Tsien, R.Y., and Taylor, S.S. (1995). Identification of a signal for rapid export of proteins from the nucleus. Cell 82, 463-473.
38. Yew, P.R., and Kirschner M.W. (1997). Proteolysis and DNA replication: the Cdc34 requirement in the xenopus egg cell cycle. Science 277, 1672-1676.